Latest Patents News

Impact Minerals reports significant advances in membrane technology integration and potash by-product recovery at its Lake Hope High Purity Alumina project, revealing a promising new large-scale potash opportunity.

Island Pharmaceuticals has been granted a key US patent for Galidesivir, extending intellectual property protection through 2031 for treating filoviridae viruses including Marburg and Ebola. This milestone aligns with the company’s clinical development strategy and recent FDA regulatory progress.

Janus Electric has secured full California Air Resources Board approval for its JCM 540 battery-electric truck conversion system, enabling fleet operators to access up to US$90,000 in government vouchers per vehicle. This milestone accelerates Janus’ entry into the lucrative California zero-emission freight market.

Memphasys Limited has extended the repayment terms of its convertible notes with major shareholder Peters Investments to mid-2026, reinforcing financial flexibility amid ongoing commercial progress.

Memphasys Limited has completed a $579K shortfall placement, boosting total funds raised to over $1.12 million to support the commercial rollout of its Felix™ System following recent regulatory approvals.

Simble Solutions has acquired exclusive rights to a cutting-edge 3D zinc oxide nanosensor technology and completed a $2.5 million placement, positioning itself to expand its IoT platform into new safety and environmental monitoring markets.

Temas Resources has completed a detailed airborne LiDAR survey at its Quebec projects, enhancing geological and engineering insights while progressing its proprietary Regenerative Chloride Leach technology aimed at slashing processing costs.

Audio Pixels has successfully developed an independent MEMS fabrication process for its second-generation digital loudspeaker, overcoming previous manufacturing hurdles and paving the way for scalable production.

Environmental Clean Technologies Limited has completed its acquisition of Terrajoule Pty Ltd, securing exclusive rights to innovative soil remediation technology, while raising $3.25 million to fuel its growth and advancing promising fertiliser trials.

Dimerix secures FDA confirmation that proteinuria reduction is a valid primary endpoint for its Phase 3 ACTION3 trial, advancing its kidney disease drug DMX-200 closer to approval.

Latrobe Magnesium Limited has received a $6.29 million R&D tax rebate from the ATO, using the funds to reduce debt and progress its magnesium production plants in Australia and Malaysia.

Elevate Uranium Ltd has expanded its global uranium resource to 169 million pounds of U3O8 through the acquisition of the Napperby Uranium Project and complementary assets from Core Lithium Ltd. This move consolidates its Central Australian portfolio and leverages its proprietary U-pgrade™ beneficiation technology.